Searched for
NITIN PAREKH
“I can’t come back at 75”: As Nandan Nilekani turns 71, Infosys faces its biggest leadership questionInfosys chairman Nandan Nilekani is entering a crucial phase. He is focused on preparing the IT giant for a future beyond its founders. Sha...- ICICI Securities maintains Hold on Infosys; lowers target price to Rs 1,470ICICI Securities maintains a Hold call on Infosys, revising the target price to Rs 1,470 due to weak guidance and global uncertainties. Inf...
- I-Sec maintains Hold call on Infosys, lowers target price to Rs 1,470ICICI Securities maintains a Hold call on Infosys, revising the target price to Rs 1,470 due to weak FY26 guidance and global economic unce...
- Buy Infosys, target price Rs 2,200: JM FinancialJM Financial has a buy call on Infosys with a target price of Rs 2200. Infosys reported a consolidated total income of Rs 42623 crore for Q...
- Add Infosys, target price Rs 2,015: HDFC SecuritiesHDFC Securities recommends adding Infosys with a target price of Rs 2015. Current price is Rs 1797.6. Infosys reported Q3 FY24 consolidated...
- Outperform rating for Infosys, target price Rs 2,225: BNP Paribas SecuritiesBNP Paribas Securities rates Infosys as outperform, targeting Rs 2,225. Current price is Rs 1939.1. Digital adoption boosts Infosys' growth...
- Buy Infosys, target price Rs 2,335: Axis SecuritiesAxis Securities recommends buying Infosys shares with a target price of Rs 2335. The current market price is Rs 1907. Infosys is a large-ca...
- Buy Infosys, target price Rs 2,200: Motilal Oswal Financial ServicesMotilal Oswal Financial Services recommends buying Infosys with a target price of Rs 2,200. Infosys reported a consolidated total income of...
- 72 scamsters have fled since 2015: Ministry of External AffairsA considerable amount of proceeds of crime is involved in these cases, which are under investigation since 2015, the ministry told the lowe...
- Planning a succession in India's business families comes with challengesThe modus operandi of passing on reins of a small- or mid-sized family business to GeNext is changing with increasing corporate complexitie...
- Will bring our latest drug Lialda by August: Nitin Kumar Parekh, Director - Finance, CadilaCadila will bring out its latest drug, Lialda, in July or August, revealed Nitin Kumar Parekh, Director - Finance, Cadila.
- ETMarkets Evening Podcast: What changed your financial fortunes all through the dayAfter days of frenetic buying, the investors on Dalal Street were seen booking profit on Monday.
- Four qualities that make a great leaderWhat is the path to great leadership — a collaborative style like Shikha Sharma or a passionate drive like Steve Jobs and Elon Musk?
- Ecommerce firms' new game plans spoil party for payment wallet companies like Oxigen and PaytmPayment wallet firms say they are getting locked out of the booming ecommerce sector as the companies prefer their own subsidiaries.
- Soon, you can shop on HDFC Bank website; customers to get best deals from Snapdeal, Flipkart, AmazonHDFC Bank is set to double up as an online shopping mart of sorts, selling grocery, clothes, shoes and other lifestyle products on its webs...
- Suits & Sayings: Wackiest whispers and murmurs in corporate corridors & policy parloursVirat Kohli pushes Pepsi and girlfriend Anushka Sharma seems to be the brand ambassador for Coca-Cola’s ‘making schools better’ campaign.
- Corruption won't go away, Kejriwal not going about the right way: Deepak Parekh"I would like to blame you, the media...you have nothing to report other than Kejriwal. Why do you give so much of importance to all this?"...
- Cadila Healthcare to set up bio-technology plant in GujPharmaceutical firm Cadila Healthcare will set up a bio-technology plant here with an investment of Rs 25 crore for manufacturing biosimila...
- Patent expiry to open huge opportunity for Indian pharmaPatent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent w...
- Stocks to watch on WednesdayEquities are likely to edge lower on Wednesday following weak global cues but second rung stocks would hog the limelight.
Load More
